Загрузка...
Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
In the studies reported here we have used topoisomerase II as a model system for analyzing the factors that determine the sites of action for DNA-binding proteins in vivo. To localize topoisomerase II sites in vivo we used an inhibitor of the purified enzyme, the antitumor drug VM-26. This drug stab...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1991
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC361479/ https://ncbi.nlm.nih.gov/pubmed/1656219 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|